C86.60
Primary cutaneous CD30-positive T-cell proliferations not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Lymphomatoid papulosis NOS
- Lymphomatoid papulosis not having achieved remission
- Lymphomatoid papulosis with failed remission
- Primary cutaneous anaplastic large cell lymphoma NOS
- Primary cutaneous anaplastic large cell lymphoma not having achieved remission
- Primary cutaneous anaplastic large cell lymphoma with failed remission
- Primary cutaneous CD30-positive large T-cell lymphoma NOS
- Primary cutaneous CD30-positive large T-cell lymphoma not having achieved remission
- Primary cutaneous CD30-positive large T-cell lymphoma with failed remission
- Primary cutaneous CD30-positive T-cell proliferations NOS
- Primary cutaneous CD30-positive T-cell proliferations with failed remission
Medical Intelligence & Overview
ICD-10 code C86.60 refers to primary cutaneous CD30-positive T-cell proliferations that have not achieved remission. These conditions are a subtype of skin lymphomas, characterized by abnormal growth of T-cells that test positive for CD30, a marker often seen in certain lymphoid cancers. When these proliferations do not resolve despite treatment, they are classified under this code. This guide aims to explain what they are, their causes, symptoms, diagnosis, and available treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations within T-cells leading to uncontrolled growth Reactivation or persistent presence of abnormal immune responses Previous skin conditions or infections triggering abnormal T-cell proliferation Exposure to certain environmental or chemical agents Immune system dysfunction or suppression
Key Symptoms: Persistent skin lesions or patches that may appear as papules, plaques, or nodules Lesions that are often reddish or skin-colored and may be itchy or tender Multiple lesions scattered across different areas of the skin Lesions that do not resolve or respond to standard treatments Possible ulceration or crusting over affected skin areas
Diagnostic & Treatment
Diagnosis Path: Diagnosing primary cutaneous CD30-positive T-cell proliferations involves a combination of clinical evaluation and laboratory tests. A skin biopsy is critical, where the removed tissue is examined under a microscope to identify characteristic cellular features. Immunohistochemistry helps confirm the presence of CD30-positive T-cells. Additional tests such as imaging studies may be performed to evaluate spread or involvement of other tissues. Differential diagnosis includes other skin conditions and lymphomas, making precise pathology assessment essential.
Treatment Protocols: Management of these proliferations aims to control disease progression and alleviate symptoms. Options include:
Clinical Advice & FAQs
Billing Guidance
Is C86.60 a billable ICD-10 code?
Yes, C86.60 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C86.60?
Clinical documentation must specify the nature of Primary cutaneous CD30-positive T-cell proliferations not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference